Method for the inhibition and prevention of viral replication using fusions of a virus protein and a destructive enzyme
AssigneeThe Johns Hopkins University
InventorsJef D Boeke, Georges Natsoulis
Life of this patent
Estimating the term…
Abstract
A new type of dominant negative gene-fusion acts as an antiviral agent when expressed in infected cells. The dominant negative effect is obtained by fusing a gene coding for a capsid or envelope protein of a virus to a gene coding for an enzyme (e.g., nuclease or protease) that can destructively hydrolyze or modify the encapsulated viral DNA, RNA or proteins. The fusion gene is expressed in virally infected cells; viruses assembled in these cells will then "self-destruct" because the fusion enzyme incorporated in the viral particles destroys or functionally alters essential components of the virus, thus preventing the virus from productively infecting another cell.
Claims1
A fusion protein, which is capable of destroying replication ability of a virus or virus-like particle, comprising:
- a capsid or envelope protein of a retrovirus or retrotransposon and a staphylococcal nuclease enzyme which is not toxic to host cells, said enzyme capable of destroying replication ability of said virus or virus-like particle.
Dependencies are inferred from the claim text.